NCT02492945View on ClinicalTrials.gov

Bundang Rehabilitative Impact Study of the Elbow Epicondylitis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

October 31, 2016

Conditions
Lateral Epicondylitis
Interventions
DRUG

3ml-Rejuvinex

They take the three times of the ultrasonography-guided 3ml-Rejuvinex as a PDRN group for four weeks(0,2,4 weeks) under double-blind.

DRUG

3ml-15%-dextrose solution

They take the three times of the ultrasonography-guided 3ml-15%-dextrose solution injections as a Dextrose group for four weeks(0,2,4 weeks) under double-blind.

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02492945 - Bundang Rehabilitative Impact Study of the Elbow Epicondylitis | Biotech Hunter | Biotech Hunter